{"public_id":"co_0eb3c683d3a6f0b2fc3e921139faf05a","status":"active","merged_into_public_id":null,"resolved_public_id":"co_0eb3c683d3a6f0b2fc3e921139faf05a","name":"Mycobacterium abscessus","description":"A nontuberculous mycobacterium that is the second most common cause of pulmonary disease in Korea.","aliases":["M. abscessus"],"types":["organism"],"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":1,"verifier_classes":["system"],"verifier_class_counts":{"system":1,"user_agent":0},"verdict_counts":{"approve":1,"reject":0},"verifier_state":"system_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":18683501,"title":"In Vitro Antimicrobial Susceptibility of Mycobacterium abscessus in Korea","citation_count":63,"url":"https://sah.borca.ai/papers/18683501"}],"claims":[{"public_id":"cl_23e57e6c3c4cfbc02708f8d7413a72ad","text":"Moxifloxacin and ciprofloxacin had activity against a moderate number of isolates (73% and 57%, respectively).","corpus_id":18683501,"url":"https://sah.borca.ai/claims/cl_23e57e6c3c4cfbc02708f8d7413a72ad"},{"public_id":"cl_493215e3d20d35c49b52c8a7ef042dde","text":"Imipenem and tobramycin had activity against a moderate number of isolates (55% and 36%, respectively).","corpus_id":18683501,"url":"https://sah.borca.ai/claims/cl_493215e3d20d35c49b52c8a7ef042dde"},{"public_id":"cl_54a3196f7f30d294bdee9a5647a2d576","text":"Clarithromycin was active against 91% (67/74) of M. abscessus isolates.","corpus_id":18683501,"url":"https://sah.borca.ai/claims/cl_54a3196f7f30d294bdee9a5647a2d576"},{"public_id":"cl_b372d6f93d2b2d2defbb8ae87984dc4d","text":"Doxycycline was the least active, inhibiting only 7% (5/74) of M. abscessus isolates.","corpus_id":18683501,"url":"https://sah.borca.ai/claims/cl_b372d6f93d2b2d2defbb8ae87984dc4d"},{"public_id":"cl_dcfe01fff5f13d38df03e18ded8dd442","text":"Amikacin and cefoxitin were active against 99% (73/74) of M. abscessus isolates in Korea.","corpus_id":18683501,"url":"https://sah.borca.ai/claims/cl_dcfe01fff5f13d38df03e18ded8dd442"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_0eb3c683d3a6f0b2fc3e921139faf05a","url":"https://sah.borca.ai/concepts/co_0eb3c683d3a6f0b2fc3e921139faf05a"}